Skip to main content
Loading market data...

GDOC holdings

Goldman Sachs Future Health Care Equity ETF

Source: SEC Form N-PORT (opens in a new tab) Holdings as of Made public 24 Jul 2026

Positions

42 stored of 42 reported, largest first by weight

GDOC holdings as of 31 May 2026, largest first
# Holding ISIN CUSIP Weight Value (USD) Type Issuer type Country Currency
1 ELI LILLY & COMPANY ELI LILLY & COMPANY COM US5324571083 532457108 13.276% $2.7M Equity (common) Corporate United States USD
2 JOHNSON & JOHNSON JOHNSON & JOHNSON COM US4781601046 478160104 8.069% $1.6M Equity (common) Corporate United States USD
3 MERCK & COMPANY INC MERCK & COMPANY INC COM US58933Y1055 58933Y105 5.944% $1.2M Equity (common) Corporate United States USD
4 GUARDANT HEALTH INC GUARDANT HEALTH INC COM US40131M1099 40131M109 5.342% $1.1M Equity (common) Corporate United States USD
5 ASTRAZENECA PLC ASTRAZENECA PLC ORD USD0.25 GB0009895292 Not reported 4.840% $974K Equity (common) Corporate United Kingdom GBP
6 THERMO FISHER SCIENTIFIC INC THERMO FISHER SCIENTIFIC INC COM US8835561023 883556102 4.522% $910K Equity (common) Corporate United States USD
7 ARGENX SE ARGENX SE SPONSORED ADR US04016X1019 04016X101 4.068% $818K Equity (common) Corporate Netherlands USD
8 INTUITIVE SURGICAL INC INTUITIVE SURGICAL INC COM NEW US46120E6023 46120E602 3.903% $785K Equity (common) Corporate United States USD
9 BOSTON SCIENTIFIC CORP BOSTON SCIENTIFIC CORP COM US1011371077 101137107 3.780% $760K Equity (common) Corporate United States USD
10 HOYA CORP HOYA CORP NPV JP3837800006 Not reported 3.529% $710K Equity (common) Corporate Japan JPY
11 EDWARDS LIFESCIENCES CORP EDWARDS LIFESCIENCES CORP COM US28176E1082 28176E108 2.983% $600K Equity (common) Corporate United States USD
12 LONZA GROUP AG LONZA GROUP AG CHF1 (REGD) CH0013841017 Not reported 2.798% $563K Equity (common) Corporate Switzerland CHF
13 DEXCOM INC DEXCOM INC COM US2521311074 252131107 2.793% $562K Equity (common) Corporate United States USD
14 AGILENT TECHNOLOGIES INC AGILENT TECHNOLOGIES INC COM US00846U1016 00846U101 2.765% $556K Equity (common) Corporate United States USD
15 ROIVANT SCIENCES LTD ROIVANT SCIENCES LTD SHS BMG762791017 Not reported 2.391% $481K Equity (common) Corporate Bermuda USD
16 CENCORA INC CENCORA INC COM US03073E1055 03073E105 2.343% $471K Equity (common) Corporate United States USD
17 APOGEE THERAPEUTICS INC APOGEE THERAPEUTICS INC COM US03770N1019 03770N101 1.969% $396K Equity (common) Corporate United States USD
18 ROYALTY PHARMA PLC ROYALTY PHARMA PLC COM USD0.0001 CLASS A GB00BMVP7Y09 Not reported 1.766% $355K Equity (common) Corporate United Kingdom USD
19 PENUMBRA INC PENUMBRA INC COM US70975L1070 70975L107 1.606% $323K Equity (common) Corporate United States USD
20 METTLER-TOLEDO INTERNATIONAL INC METTLER-TOLEDO INTERNATIONAL INC COM US5926881054 592688105 1.590% $320K Equity (common) Corporate United States USD
21 VERTEX PHARMACEUTICALS INC VERTEX PHARMACEUTICALS INC COM US92532F1003 92532F100 1.484% $299K Equity (common) Corporate United States USD
22 GOLDMAN SACHS TRUST Goldman Sachs Financial Square Treasury Obligations Fund US38141W3236 38141W323 1.432% $288K Short-term investment vehicles (cash funds) Registered fund United States USD
23 CYTOKINETICS INC CYTOKINETICS INC COM NEW US23282W6057 23282W605 1.398% $281K Equity (common) Corporate United States USD
24 IONIS PHARMACEUTICALS INC IONIS PHARMACEUTICALS INC COM US4622221004 462222100 1.374% $276K Equity (common) Corporate United States USD
25 XENON PHARMACEUTICALS INC XENON PHARMACEUTICALS INC COM CA98420N1050 98420N105 1.354% $272K Equity (common) Corporate Canada USD
26 UNITEDHEALTH GROUP INC UNITEDHEALTH GROUP INC COM US91324P1021 91324P102 1.352% $272K Equity (common) Corporate United States USD
27 REPLIGEN CORP REPLIGEN CORP COM US7599161095 759916109 1.256% $253K Equity (common) Corporate United States USD
28 INSMED INC INSMED INC COM PAR $.01 US4576693075 457669307 1.106% $222K Equity (common) Corporate United States USD
29 GALDERMA GROUP AG GALDERMA GROUP AG CHF0.01 CH1335392721 Not reported 1.096% $220K Equity (common) Corporate Switzerland CHF
30 MADRIGAL PHARMACEUTICALS INC MADRIGAL PHARMACEUTICALS INC COM US5588681057 558868105 1.063% $214K Equity (common) Corporate United States USD
31 REVOLUTION MEDICINES INC REVOLUTION MEDICINES INC COM US76155X1000 76155X100 0.837% $168K Equity (common) Corporate United States USD
32 CG ONCOLOGY INC CG ONCOLOGY INC COM US1569441009 156944100 0.753% $151K Equity (common) Corporate United States USD
33 BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC COM US10806X1028 10806X102 0.729% $147K Equity (common) Corporate United States USD
34 QUEST DIAGNOSTICS INC QUEST DIAGNOSTICS INC COM US74834L1008 74834L100 0.718% $144K Equity (common) Corporate United States USD
35 RHYTHM PHARMACEUTICALS INC RHYTHM PHARMACEUTICALS INC COM US76243J1051 76243J105 0.675% $136K Equity (common) Corporate United States USD
36 ALKERMES PLC ALKERMES PLC SHS IE00B56GVS15 Not reported 0.567% $114K Equity (common) Corporate Ireland USD
37 SARTORIUS STEDIM BIOTECH SA SARTORIUS STEDIM BIOTECH SA EUR0.20 FR0013154002 Not reported 0.551% $111K Equity (common) Corporate France EUR
38 PRAXIS PRECISION MEDICINES INC PRAXIS PRECISION MEDICINES INC COM NEW US74006W2070 74006W207 0.550% $111K Equity (common) Corporate United States USD
39 DEFINIUM THERAPEUTICS INC DEFINIUM THERAPEUTICS INC COM SHS CA24477V1058 24477V105 0.507% $102K Equity (common) Corporate Canada USD
40 SPYRE THERAPEUTICS INC SPYRE THERAPEUTICS INC COM NEW US00773J2024 00773J202 0.351% $71K Equity (common) Corporate United States USD
41 INSULET CORP INSULET CORP COM US45784P1012 45784P101 0.287% $58K Equity (common) Corporate United States USD
42 STRUCTURE THERAPEUTICS INC STRUCTURE THERAPEUTICS INC SPONSORED ADS US86366E1064 86366E106 0.197% $40K Equity (common) Corporate Cayman Islands USD
IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme